Department of Microbiology, University of Central Punjab Lahore, Pakistan.
Académie Internationale de Médecine Dentaire Intégrative, Paris, France.
Arch Razi Inst. 2022 Dec 31;77(6):2065-2072. doi: 10.22092/ARI.2022.359856.2486. eCollection 2022 Dec.
Tuberculosis is one of the predominant infectious diseases causing significant deaths worldwide. Detection of bacilli (MTB) using culture media was officially recognized by World Health Organization. However, there is a significant limitation in the authenticity of evaluation for its effectiveness on clinically important attributes. GeneXpert detects the presence of () based on the detection of nucleic acid and is able to identify the resistance of both isoniazid (INH) and Rifampicin (RIF) drugs. In this technique, DNA amplification is done using the GeneXpert instrument in the suspected sample with a specific reagent cartridge. Although GeneXpert is a rapid technique compared to other diagnostic tools for MTB identification due to false-negative results, the culture media technique is still considered the gold standard in detecting . The current study was designed to evaluate the comparative efficacies of GeneXpert and the solid culture media technique in identifying MTB. Sputum samples of 250 (n=250) suspected tuberculosis (TB) patients were investigated using both diagnostic techniques. The results revealed that out of the 250 suspected patients, 30 (12%) samples were positive with the culture media technique, while only 17 (6.8%) samples showed positive results with GeneXpert. Culture tests and GeneXpert are not equally efficient in detecting . The current study's findings showed that the culture-based detection method for is more efficient and reliable than GeneXpert.
结核病是全球主要传染病之一,导致大量死亡。世界卫生组织正式承认使用培养基检测杆菌(MTB)。然而,其在评估临床重要属性方面的有效性的真实性存在重大局限性。GeneXpert 基于核酸检测来检测 的存在,并能够识别异烟肼(INH)和利福平(RIF)药物的耐药性。在该技术中,使用特定的试剂盒在可疑样本中使用 GeneXpert 仪器进行 DNA 扩增。尽管与其他用于 MTB 鉴定的诊断工具相比,GeneXpert 是一种快速技术,但由于假阴性结果,培养基技术仍然被认为是检测 的金标准。本研究旨在评估 GeneXpert 和固体培养基技术在鉴定 MTB 方面的比较疗效。使用两种诊断技术研究了 250 名(n=250)疑似肺结核(TB)患者的痰液样本。结果显示,在 250 名疑似患者中,有 30 份(12%)样本用培养基技术呈阳性,而仅有 17 份(6.8%)样本用 GeneXpert 呈阳性。培养试验和 GeneXpert 对 检测的效率并不相同。本研究结果表明,基于培养的 检测方法比 GeneXpert 更有效和可靠。